| $337M | ||
| $259M | ||
| $79M | ||
| $60M | ||
| $58M | ||
| $50M |
Buys | $50,302,794 | 6 | 67 |
Sells | $389,352 | 3 | 33 |
| RA CAPITAL MANAGEMENT, L.P. | 1 | $50M | 0 | $0 | $50M | |
| McWherter Charles | director | 3 | $179,850 | 0 | $0 | $179,850 |
| PALEKAR ROHAN | Chief Executive Officer | 2 | $122,950 | 0 | $0 | $122,950 |
| Le-Nguyen Quoc | See Remarks | 0 | $0 | 3 | $389,352 | $-389,352 |
89bio, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapies for the treatment of liver and cardio-metabolic diseases. Its lead product candidate is pegozafermin, a glycoPEGylated analog of fibroblast growth factor 21 for the treatment of nonalcoholic steatohepatitis. The company also intends to develop pegozafermin for the treatment of severe hypertriglyceridemia. 89bio, Inc. was incorporated in 2018 and is headquartered in San Francisco, California.
Over the last 12 months, insiders at 89bio, Inc. have bought $50.3M and sold $389,352 worth of 89bio, Inc. stock.
On average, over the past 5 years, insiders at 89bio, Inc. have bought $48.01M and sold $4.57M worth of stock each year.
Highest buying activity among insiders over the last 12 months: RA CAPITAL MANAGEMENT, L.P. () — $50M. McWherter Charles (director) — $179,850. PALEKAR ROHAN (Chief Executive Officer) — $122,950.
The last purchase of 5,714,285 shares for transaction amount of $50M was made by RA CAPITAL MANAGEMENT, L.P. () on 2025‑01‑30.
| 2025-04-15 | Sale | Le-Nguyen Quoc | See Remarks | 15,329 0.0114% | $5.95 | $91,208 | +40.21% | |
| 2025-01-30 | RA CAPITAL MANAGEMENT, L.P. | 5.71M 4.871% | $8.75 | $50M | -11.31% | |||
| 2025-01-22 | McWherter Charles | director | 10,000 0.0085% | $6.71 | $67,100 | +27.33% | ||
| 2025-01-21 | McWherter Charles | director | 5,000 0.0042% | $6.55 | $32,750 | +29.94% | ||
| 2025-01-15 | Sale | Le-Nguyen Quoc | See Remarks | 10,963 0.0096% | $6.49 | $71,150 | +36.12% | |
| 2024-12-06 | PALEKAR ROHAN | Chief Executive Officer | 5,000 0.0041% | $7.89 | $39,450 | -0.50% | ||
| 2024-12-05 | McWherter Charles | director | 10,000 0.0086% | $8.00 | $80,000 | +1.84% | ||
| 2024-11-22 | PALEKAR ROHAN | Chief Executive Officer | 10,000 0.0081% | $8.35 | $83,500 | -7.59% | ||
| 2024-10-30 | Sale | Le-Nguyen Quoc | See Remarks | 27,955 0.0268% | $8.12 | $226,995 | +4.00% | |
| 2024-04-01 | Sale | PALEKAR ROHAN | Chief Executive Officer | 52,718 0.0573% | $10.91 | $575,153 | -21.16% | |
| 2024-03-04 | RA CAPITAL MANAGEMENT, L.P. | 1.35M 1.6718% | $15.35 | $20.72M | -37.80% | |||
| 2024-02-26 | Sale | PALEKAR ROHAN | Chief Executive Officer | 4,477 0.0047% | $10.76 | $48,173 | -21.94% | |
| 2023-12-29 | Sale | PALEKAR ROHAN | Chief Executive Officer | 50,000 0.0549% | $11.20 | $560,000 | -21.53% | |
| 2023-07-17 | Sale | LAPORTE KATHLEEN | director | 12,500 0.024% | $18.80 | $235,000 | -44.87% | |
| 2023-06-05 | Sale | PALEKAR ROHAN | Chief Executive Officer | 15,000 0.0282% | $20.00 | $300,000 | -44.70% | |
| 2023-06-01 | Sale | Atkinson Edward Morrow III | director | 6,250 0.0112% | $17.91 | $111,938 | -41.26% | |
| 2023-05-09 | Sale | Le-Nguyen Quoc | See Remarks | 13,683 0.0258% | $18.11 | $247,799 | -36.44% | |
| 2023-04-04 | Sale | Martins Ryan | Chief Financial Officer | 8,721 0.0165% | $14.95 | $130,379 | -2.83% | |
| 2023-03-28 | Hayden Michael R | director | 61,538 0.112% | $16.15 | $993,839 | -10.96% | ||
| 2023-03-24 | RA CAPITAL MANAGEMENT, L.P. | 2.46M 4.6238% | $16.25 | $40M | -7.31% |
| RA CAPITAL MANAGEMENT, L.P. | 19554319 13.3948% | $195.54M | 11 | 0 | <0.0001% | |
| PALEKAR ROHAN | Chief Executive Officer | 471236 0.3228% | $4.71M | 6 | 5 | <0.0001% |
| Le-Nguyen Quoc | See Remarks | 328323 0.2249% | $3.28M | 0 | 5 | |
| McWherter Charles | director | 25000 0.0171% | $250,000.00 | 3 | 0 | |
| Shah Rajeev M. | 7782669 5.3312% | $77.83M | 1 | 0 | +239.97% | |
| Longitude Capital Partners III, LLC | 10 percent owner | 2600877 1.7816% | $26.01M | 2 | 0 | +2.62% |
| Naschitz Anat | 1864721 1.2773% | $18.65M | 1 | 1 | +28.8% | |
| ORBIMED ADVISORS LLC | 10 percent owner | 1829433 1.2532% | $18.29M | 1 | 3 | +28.8% |
| Kariv Tomer | 250000 0.1713% | $2.5M | 1 | 0 | +28.8% | |
| Hayden Michael R | director | 61538 0.0422% | $615,380.00 | 8 | 0 | +100.22% |
| Martins Ryan | Chief Financial Officer | 53578 0.0367% | $535,780.00 | 0 | 7 | |
| LAPORTE KATHLEEN | director | 0 0% | $0 | 0 | 1 | |
| Grunberg Gregory | director | 0 0% | $0 | 2 | 1 | +2.62% |
| Waisbourd Ram | See Remarks | 0 0% | $0 | 0 | 15 | |
| Atkinson Edward Morrow III | director | 0 0% | $0 | 0 | 2 |
$193,151,375 | 134 | 8.18% | $1.76B | |
$54,590,806 | 65 | 21.84% | $1.33B | |
$11,583,737 | 45 | 49.75% | $1.28B | |
$100,002,191 | 42 | 21.48% | $1.17B | |
$530,111,731 | 35 | 8.69% | $1.35B | |
$148,770,544 | 34 | 80.63% | $1.33B | |
89bio, Inc. (ETNB) | $309,951,506 | 30 | 32.56% | $1.46B |
$1,295,059 | 29 | 102.78% | $1.38B | |
$150,253,463 | 26 | -52.83% | $1.69B | |
$96,400,802 | 19 | 32.48% | $1.47B | |
$92,580,864 | 14 | -1.28% | $1.52B | |
$137,027,226 | 13 | 28.32% | $1.63B | |
$43,198,628 | 12 | -0.10% | $1.22B | |
$32,575,266 | 8 | 37.03% | $1.73B | |
$107,098,946 | 7 | 1.61% | $1.34B | |
$21,792,890 | 6 | 75.72% | $1.56B | |
$91,325,021 | 6 | 1.83% | $1.23B | |
$10,000,009 | 1 | 100.92% | $1.73B | |
$5,000,000 | 1 | -22.84% | $1.59B |
| Increased Positions | 144 | +112.5% | 50M | +41.49% |
| Decreased Positions | 59 | -46.09% | 17M | -14.12% |
| New Positions | 53 | New | 17M | New |
| Sold Out Positions | 25 | Sold Out | 7M | Sold Out |
| Total Postitions | 213 | +66.41% | 155M | +27.37% |
| Janus Henderson Group Plc | $144,168.00 | 11.31% | 16.51M | +1M | +8.95% | 2024-12-31 |
| Ra Capital Management, L.P. | $123,751.00 | 9.71% | 14.18M | 0 | 0% | 2024-12-31 |
| Suvretta Capital Management, Llc | $89,070.00 | 6.99% | 10.2M | +2M | +27.67% | 2024-12-31 |
| Blackrock, Inc. | $87,958.00 | 6.9% | 10.08M | +2M | +27.7% | 2025-03-31 |
| Rtw Investments, Lp | $65,283.00 | 5.12% | 7.48M | +99,513 | +1.35% | 2024-12-31 |
| Deep Track Capital, Lp | $56,555.00 | 4.44% | 6.48M | +4M | +134.17% | 2024-12-31 |
| Vanguard Group Inc | $49,694.00 | 3.9% | 5.69M | +686,054 | +13.7% | 2024-12-31 |
| Citadel Advisors Llc | $41,292.00 | 3.24% | 4.73M | +2M | +85% | 2024-12-31 |
| Bvf Inc/Il | $37,835.00 | 2.97% | 4.33M | -2M | -36.38% | 2024-12-31 |
| Pictet Asset Management Holding Sa | $36,709.00 | 2.88% | 4.2M | +1M | +39.84% | 2025-03-31 |